BE
Beam Therapeutics
BEAM · NASDAQ
$26.83 +0.48% (+$0.13)
1M -1.65%
Market Cap $2.76B
P/E Ratio -
Div. Yield -
ROE 7.70%
Bulios Fair Price
$18.59
30.7% downside
Trenutna cena
$26.83
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BEAM trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
37 /100
Fair P/S 17.69x
P/B 2.59x
P/E N/A
Growth
100 /100
Growing Rev. growth 31.88%
Book val. growth 19.07%
EPS growth N/A
Profitability
5 /100
Weak Gross margin 18.93%
Net margin 54.75%
Op. margin 242.27%
Quality
1 /100
Poor ROIC 28.62%
ROE 7.70%
ROA 6.16%
Debt
69 /100
Low Debt/Equity 0.23x
Current ratio 14.57x
Int. coverage -7.76x
Stability
1 /100
Unstable Beta 2.21x
Rev. volatility 306.90%
EPS volatility 137.13%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BEAM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Evans
Employees
540
Headquarters
Cambridge
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report